Decontamination of prions in a plasma product manufacturing environment-Reference-Cited by-同舟云学术

Decontamination of prions in a plasma product manufacturing environment

Published:2013-08-27 Issue:4 Volume:54 Page:1028-1036
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Bellon Anne¹,Comoy Emmanuel²,Simoneau Steve¹,Mornac Sandrine¹,Dehen Capucine²,Perrin Audrey²,Arzel Aude¹,Arrabal Samuel¹,Baron Henry³,Laude Hubert⁴,You Bruno¹,Deslys Jean-Philippe²,Flan Benoit¹

Affiliation:

1. LFB; Les Ulis France

2. CEA; Institute of Emerging Diseases and Innovative Therapies (iMETI), Division of Prions and Related Diseases (SEPIA); Fontenay-aux-Roses France

3. Atlantic Biotech S.R.O.; Prague Czech Republic

4. INRA; U892 Virologie Immunologie Moléculaires; Jouy en Josas France

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12381/fullpdf

Reference36 articles.

1. Molecular biology of prion diseases;Prusiner;Science,1991

2. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion;Llewelyn;Lancet,2004

3. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient;Peden;Lancet,2004

4. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report;Wroe;Lancet,2006

5. Health protection report Volume 1 Number 3 published on the 19th of January 2007 “Current news” Fourth case of transfusion-associated variant-CJD infection [monograph on the internet] 2007 http://www.hpa.org.uk/hpr/archives/2007/hpr0307.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt–Jakob disease;Vox Sanguinis;2023-03-07

2. Out of sight, out of mind? BSE 30 years on: continuing environmental risks to human health;Land Use Policy;2023-03

3. Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review;Health Technology Assessment;2020-02

4. Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies;Acta Neuropathologica;2018-11-27

5. Pathogen Safety;Biopharmaceutical Processing;2018